Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the potential differences in GI safety and tolerability
in the small bowel between lumiracoxib, conventional non-selective NSAID (naproxen) with a
proton pump inhibitor (omeprazole), or placebo.